Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

HILT vs ESWT in Supraspinatus Tendinitis

25 mai 2026 mis à jour par: sami abdu akkur, Kafrelsheikh University

Comparative Effectiveness of High-Intensity Laser Therapy Versus Extracorporeal Shock Wave Therapy in Patients With Supraspinatus Tendinitis

This randomized controlled trial aims to compare the effectiveness of High-Intensity Laser Therapy (HILT) and Extracorporeal Shock Wave Therapy (ESWT) in patients with supraspinatus tendinitis.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

48

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

  • Adulte

Accepte les volontaires sains

Non

La description

Inclusion Criteria:

  • Male and female participants aged between 18 and 60 years.
  • Clinically diagnosed supraspinatus tendinitis confirmed by ultrasound imaging.
  • Shoulder pain duration greater than 3 months.
  • Ability to understand and follow study instructions.
  • Willingness to participate and provide informed consent.

Exclusion Criteria:

  • Full-thickness rotator cuff tear.
  • Previous shoulder surgery.
  • Pregnancy.
  • Neurological disorders affecting the upper limb.
  • Corticosteroid injection within the previous 3 months.
  • Shoulder fracture or dislocation.
  • Systemic inflammatory diseases.
  • Participation in other physical therapy programs during the study period

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: Randomisé
  • Modèle interventionnel: Affectation parallèle
  • Masquage: Seul

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Comparateur actif: Group A: HILT + Conventional PT
High-Intensity Laser Therapy (HILT) is an advanced electrotherapy modality that uses high-power laser energy to penetrate deep musculoskeletal tissues and stimulate biological healing processes. The device emits laser wavelengths ranging between 808-1064 nm with high peak power output, allowing deeper tissue penetration compared to conventional low-level laser therapy. HILT provides analgesic, anti-inflammatory, and biostimulatory effects through increasing local blood circulation, enhancing cellular metabolism, stimulating collagen synthesis, and promoting tissue regeneration. The treatment is non-invasive, safe, and commonly used in musculoskeletal rehabilitation, particularly for tendinopathies and chronic pain conditions.
The conventional physical therapy program consisted of a combination of therapeutic exercises and physical therapy modalities aimed at reducing pain, improving shoulder range of motion, enhancing muscle strength, and restoring functional performance. The program included hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), stretching exercises, range of motion exercises, strengthening exercises for the rotator cuff and scapular stabilizers, as well as a home exercise program. Treatment sessions were conducted three times per week according to the patient's tolerance and clinical condition
Comparateur actif: Group B: ESWT + Conventional PT
The conventional physical therapy program consisted of a combination of therapeutic exercises and physical therapy modalities aimed at reducing pain, improving shoulder range of motion, enhancing muscle strength, and restoring functional performance. The program included hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), stretching exercises, range of motion exercises, strengthening exercises for the rotator cuff and scapular stabilizers, as well as a home exercise program. Treatment sessions were conducted three times per week according to the patient's tolerance and clinical condition
Extracorporeal Shock Wave Therapy (ESWT) is a non-invasive therapeutic modality that delivers high-energy acoustic waves to injured musculoskeletal tissues. The device generates focused or radial shock waves that stimulate tissue healing, neovascularization, pain reduction, and cellular repair mechanisms. ESWT is widely used in the management of tendinopathies, calcific disorders, and chronic musculoskeletal pain. Treatment parameters typically include energy flux density, frequency, number of impulses, and treatment sessions. The therapy is considered safe and effective, with minimal side effects
Comparateur actif: Group C: Conventional Physical Therapy Only
The conventional physical therapy program consisted of a combination of therapeutic exercises and physical therapy modalities aimed at reducing pain, improving shoulder range of motion, enhancing muscle strength, and restoring functional performance. The program included hot pack application, Transcutaneous Electrical Nerve Stimulation (TENS), stretching exercises, range of motion exercises, strengthening exercises for the rotator cuff and scapular stabilizers, as well as a home exercise program. Treatment sessions were conducted three times per week according to the patient's tolerance and clinical condition

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Pain intensity measured using Visual Analogue Scale (VAS).
Délai: At baseline and immediately after 4 weeks of intervention
Pain intensity will be assessed using the Visual Analogue Scale (VAS), where 0 indicates no pain and 10 indicates worst imaginable pain.
At baseline and immediately after 4 weeks of intervention

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Shoulder Pain and Disability Measured by the Shoulder Pain and Disability Index (SPADI)
Délai: At baseline and immediately after 4 weeks of intervention
Shoulder pain and disability will be assessed using the Shoulder Pain and Disability Index (SPADI). The SPADI score ranges from 0 to 100, with higher scores indicating greater pain and disability.
At baseline and immediately after 4 weeks of intervention
Upper Extremity Function Measured by the Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH)
Délai: Time Frame: Baseline and immediately after 4 weeks of intervention.
Upper extremity function will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. DASH scores range from 0 to 100, with higher scores indicating greater disability.
Time Frame: Baseline and immediately after 4 weeks of intervention.
Shoulder Range of Motion Measured Using a Digital Goniometer
Délai: Baseline and immediately after 4 weeks of intervention.
Shoulder range of motion (flexion, abduction, and external rotation) will be measured in degrees using a digital goniometer. Higher values indicate greater shoulder mobility.
Baseline and immediately after 4 weeks of intervention.
Quality of Life Measured by the Short Form-36 Health Survey (SF-36)
Délai: Baseline and immediately after 4 weeks of intervention.
Quality of life will be assessed using the Short Form-36 Health Survey (SF-36). Scores range from 0 to 100, with higher scores indicating better health-related quality of life.
Baseline and immediately after 4 weeks of intervention.

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Les enquêteurs

  • Directeur d'études: Yasmin Mohamed Mahmoud, Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy
  • Chaise d'étude: Mahmoud Mohamed Ewida, PHD, Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy
  • Directeur d'études: Shaimaa Ramadan Eldeab, PHD, Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy
  • Chercheur principal: Sami ABDU Akkur, MASTER DEGREE STUDENT, Kafrelsheikh University Faculty of Physical Therapy Department of Basic Sciences for Physical Therapy

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 août 2026

Achèvement primaire (Estimé)

30 octobre 2026

Achèvement de l'étude (Estimé)

30 décembre 2027

Dates d'inscription aux études

Première soumission

19 mai 2026

Première soumission répondant aux critères de contrôle qualité

25 mai 2026

Première publication (Réel)

29 mai 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

29 mai 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

25 mai 2026

Dernière vérification

1 mai 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • KFSIRB200-1036

Plan pour les données individuelles des participants (IPD)

Prévoyez-vous de partager les données individuelles des participants (DPI) ?

INDÉCIS

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner